PURPOSE: To evaluate the ability of new Swept source (SS) optical coherence tomography (OCT) technology to detect changes in retinal and choroidal thickness in patients with Parkinson's disease (PD). DESIGN: Observational case-control cross sectional study, developed from January to May 2016. METHODS: In total, 50 eyes from 50 patients diagnosed with PD and 54 eyes of 54 healthy controls underwent retinal and choroidal assessment using SS DRI Triton OCT (Topcon), using the 3D Wide protocol. Total macular thickness and peripapillary data (retinal, ganglion cell layer [GCL+, GCL++] and retinal nerve fiber layer [RNFL] thickness) were analyzed. Macular and peripapillary choroidal thickness was evaluated (Figure 1). RESULTS: Significant peripapillary retinal thinning was observed in PD patients in total average (p = 0.017), in the nasal (p = 0.038) and temporal (p = 0.004) quadrants and in superotemporal (p = 0.004), nasal (p = 0.039), inferotemporal (p = 0.019), and temporal (p = 0.003) sectors. RNFL and GCL ++ thickness showed a significant reduction in the inferotemporal sector (p = 0.026 and 0.009, respectively). No differences were observed in macular retinal thickness between controls and patients. Choroidal thickness was found to have increased in all sectors in PD patients compared with controls, both in the macular (inner nasal, p = 0.015; inner inferior, p = 0.030; outer nasal, p = 0.012; outer inferior, p = 0.049) and the peripapillary area (total thickness, p = 0.011; nasal, p = 0.025; inferior, p = 0.007; temporal, p = 0.003; inferotemporal, p = 0.003; inferonasal, p = 0.016) Conclusion: New SS technology for OCT devices detects retinal thinning in PD patients, providing increased depth analysis of the choroid in these patients. The choroid in PD may present increased thickness compared to healthy individuals; however, more studies and histological analysis are needed to corroborate our findings.
PURPOSE: To evaluate the ability of new Swept source (SS) optical coherence tomography (OCT) technology to detect changes in retinal and choroidal thickness in patients with Parkinson's disease (PD). DESIGN: Observational case-control cross sectional study, developed from January to May 2016. METHODS: In total, 50 eyes from 50 patients diagnosed with PD and 54 eyes of 54 healthy controls underwent retinal and choroidal assessment using SS DRI Triton OCT (Topcon), using the 3D Wide protocol. Total macular thickness and peripapillary data (retinal, ganglion cell layer [GCL+, GCL++] and retinal nerve fiber layer [RNFL] thickness) were analyzed. Macular and peripapillary choroidal thickness was evaluated (Figure 1). RESULTS: Significant peripapillary retinal thinning was observed in PDpatients in total average (p = 0.017), in the nasal (p = 0.038) and temporal (p = 0.004) quadrants and in superotemporal (p = 0.004), nasal (p = 0.039), inferotemporal (p = 0.019), and temporal (p = 0.003) sectors. RNFL and GCL ++ thickness showed a significant reduction in the inferotemporal sector (p = 0.026 and 0.009, respectively). No differences were observed in macular retinal thickness between controls and patients. Choroidal thickness was found to have increased in all sectors in PDpatients compared with controls, both in the macular (inner nasal, p = 0.015; inner inferior, p = 0.030; outer nasal, p = 0.012; outer inferior, p = 0.049) and the peripapillary area (total thickness, p = 0.011; nasal, p = 0.025; inferior, p = 0.007; temporal, p = 0.003; inferotemporal, p = 0.003; inferonasal, p = 0.016) Conclusion: New SS technology for OCT devices detects retinal thinning in PDpatients, providing increased depth analysis of the choroid in these patients. The choroid in PD may present increased thickness compared to healthy individuals; however, more studies and histological analysis are needed to corroborate our findings.
Authors: Vicente Polo; Maria Satue; Alicia Gavin; Elisa Vilades; Elvira Orduna; Marta Cipres; Javier Garcia-Campayo; Mayte Navarro-Gil; Jose M Larrosa; Luis E Pablo; Elena Garcia-Martin Journal: Eye (Lond) Date: 2018-10-31 Impact factor: 3.775
Authors: Elena Garcia-Martin; Laura Jarauta; Elisa Vilades; Jose Ramon Ara; Jesus Martin; Vicente Polo; Jose Manuel Larrosa; Luis Emilio Pablo; Maria Satue Journal: J Ophthalmol Date: 2018-11-13 Impact factor: 1.909
Authors: Elena Garcia-Martin; Marta Cipres; Isabel Melchor; Laura Gil-Arribas; Elisa Vilades; Vicente Polo; Maria Jesus Rodrigo; Maria Satue Journal: J Ophthalmol Date: 2019-08-07 Impact factor: 1.909
Authors: L Boquete; E López-Guillén; E Vilades; J M Miguel-Jiménez; L E Pablo; L De Santiago; M Ortiz Del Castillo; M C Alonso-Rodríguez; E M Sánchez Morla; A López-Dorado; E Garcia-Martin Journal: PLoS One Date: 2019-11-08 Impact factor: 3.240
Authors: Gregory L Brown; Mona L Camacci; Sean D Kim; Stephanie Grillo; James V Nguyen; Douglas A Brown; Sarah P Ullah; Mechelle M Lewis; Guangwei Du; Lan Kong; Jeffrey M Sundstrom; Xuemei Huang; Esther M Bowie Journal: J Parkinsons Dis Date: 2021 Impact factor: 5.568